[LGND] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
31-Oct-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -19.60%
YoY- -34.86%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 33,375 21,619 17,701 14,973 13,005 6,375 5,741 34.05%
PBT 12,071 804 7,284 901 2,025 -52 -3,884 -
Tax 3,645 160 -217,255 124 60 142 22 134.17%
NP 8,426 644 199,165 1,280 1,965 -194 -3,906 -
Tax Rate -30.20% -19.90% 2,982.63% -13.76% -2.96% - - -
Total Cost 24,949 20,975 -181,464 13,693 11,040 6,569 9,647 17.14%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 25.25 2.98 1,125.16 8.55 15.11 -3.04 -68.04 -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS 0.40 0.03 10.01 0.06 0.10 -0.01 -0.20 -
EPS Diluted 0.36 0.03 9.28 0.06 0.09 -0.01 -0.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.